RavenQuest BioMed Inc. (RVVQF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
RavenQuest BioMed Inc. (RVVQF) trades at $0.00 with AI Score 61/100 (Grade B+). RavenQuest BioMed Inc. is a Canadian cannabis company focused on production, management services, consulting, and R&D. Market cap: $1,236, Sector: Healthcare.
Last analyzed: Mar 16, 2026Analyst Coverage for RVVQF: RVVQF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates RVVQF against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
RVVQF: 2/4 perspectives are bearish. Dominant signal: Seth Klarman bearish.
RavenQuest BioMed Inc. (RVVQF) Healthcare & Pipeline Overview
RavenQuest BioMed Inc. is a Canadian cannabis company involved in cannabis production, consulting, and R&D, operating in the evolving specialty and generic drug manufacturing sector. With a focus on cultivation and sales, RavenQuest markets its products under the Lore Cannabis and Bloomera brands, navigating the complexities of the cannabis industry.
What Is the Investment Thesis for RVVQF?
RavenQuest BioMed Inc. presents a speculative investment opportunity within the cannabis sector. The company's focus on both consulting services and cannabis cultivation offers diversified revenue streams. However, the company's negative P/E ratio of -0.00 and a significantly negative profit margin of -2423.9% indicate substantial financial challenges. The gross margin of 63.7% suggests potential profitability in its core operations, but overall financial performance needs improvement. Upcoming catalysts include potential regulatory changes in the cannabis industry and expansion of its product lines under the Lore Cannabis and Bloomera brands. Investors should carefully consider the risks associated with OTC-listed companies and the volatile nature of the cannabis market.
Based on FMP financials and quantitative analysis
RVVQF Key Highlights
- Market Cap of $0.00B indicates a micro-cap company with limited financial resources.
- Negative P/E Ratio of -0.00 reflects the company's current lack of profitability.
- Profit Margin of -2423.9% highlights significant operational inefficiencies and high costs.
- Gross Margin of 63.7% suggests potential for profitability if operational costs are managed effectively.
- Beta of -0.23 indicates a low correlation with the overall market, potentially offering some downside protection during market downturns.
Who Are RVVQF's Competitors?
RVVQF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AVTBF Avant Brands Inc. | $0.46 | -2.00% | $5.30M | 40 |
| CPIVF Captiva Verde Wellness Corp. | $0.03 | -1.72% | 9M | 48 |
| MVMDF Mountain Valley MD Holdings Inc. | $0.05 | -1.97% | $16.81M | 50 |
| ALVO Alvotech | $4.17 | -1.18% | 2B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
| INNPF INNOCAN PHARMA Corp | $2.40 | -2.04% | $10.80M | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are RVVQF's Key Strengths?
- Established brands (Lore Cannabis and Bloomera).
- Diversified revenue streams (cultivation, consulting).
- Expertise in cannabis cultivation and management.
- Strong gross margin (63.7%).
What Are RVVQF's Weaknesses?
- Negative profit margin (-2423.9%).
- Limited market capitalization ($0.00B).
- OTC listing indicates higher risk.
- Dependence on evolving cannabis regulations.
What Could Drive RVVQF Stock Higher?
- Potential changes in cannabis regulations in Canada.
- Expansion of product lines under the Lore Cannabis and Bloomera brands.
- Increasing demand for medical cannabis products.
- Growth of the cannabis consulting services market.
What Are the Key Risks for RVVQF?
- Intense competition in the cannabis industry.
- Fluctuations in cannabis prices.
- Negative publicity and reputational damage.
- Dependence on evolving cannabis regulations.
- Limited financial resources and negative profitability.
What Are the Growth Opportunities for RVVQF?
- Expansion of Cultivation Capacity: RavenQuest can increase its revenue and market share by expanding its cannabis cultivation facilities. The Canadian cannabis market is projected to reach several billion dollars in the coming years, providing a substantial opportunity for growth. Timeline: Ongoing, with potential for significant expansion within the next 2-3 years. Competitive advantage: Enhanced production efficiency and economies of scale.
- Product Line Diversification: Developing and launching new cannabis products under the Lore Cannabis and Bloomera brands can attract a broader customer base. The market for cannabis-infused products, such as edibles and beverages, is growing rapidly. Timeline: Within the next 1-2 years. Competitive advantage: Innovation in product formulations and branding.
- Strategic Partnerships: Forming partnerships with other companies in the cannabis industry, such as distributors and retailers, can expand RavenQuest's market reach. Collaborations can also lead to the development of new products and technologies. Timeline: Ongoing. Competitive advantage: Access to established distribution networks and expertise.
- International Expansion: As cannabis regulations evolve globally, RavenQuest can explore opportunities to expand into international markets. Countries such as Germany and Australia are showing increasing acceptance of medical cannabis. Timeline: 3-5 years. Competitive advantage: Early mover advantage in emerging markets.
- Consulting Services Growth: Leveraging its expertise in cannabis production and management, RavenQuest can expand its consulting services to other cannabis businesses. The demand for consulting services is growing as new companies enter the market and existing companies seek to improve their operations. Timeline: Ongoing. Competitive advantage: Proven track record and industry knowledge.
What Opportunities Does RVVQF Have?
- Expansion of cultivation capacity.
- Product line diversification (edibles, beverages).
- Strategic partnerships with distributors and retailers.
- International expansion into emerging markets.
What Threats Does RVVQF Face?
- Intense competition in the cannabis industry.
- Changing cannabis regulations and licensing requirements.
- Fluctuations in cannabis prices.
- Potential for negative publicity and reputational damage.
What Are RVVQF's Competitive Advantages?
- Brand recognition through Lore Cannabis and Bloomera brands.
- Expertise in cannabis cultivation and management.
- Established consulting services business.
What Does RVVQF Do?
RavenQuest BioMed Inc., incorporated in 1987 and rebranded in September 2017, is a Canadian cannabis company headquartered in Vancouver. The company operates in the burgeoning cannabis industry, focusing on cannabis production, management services, consulting, and specialized research and development activities. RavenQuest BioMed operates through two primary segments: Consulting Business, which provides expertise and support to other cannabis businesses, and Cultivation and Sale of Medical Cannabis, which involves the production and distribution of cannabis products. The company's products are marketed under the brand names Lore Cannabis and Bloomera, targeting different segments within the cannabis market. RavenQuest's strategic focus includes expanding its cultivation capabilities and developing innovative cannabis products. The company aims to establish a strong presence in the Canadian cannabis market and potentially expand into international markets as regulations evolve. RavenQuest BioMed Inc. continues to adapt to the changing regulatory landscape and market dynamics within the cannabis industry.
What Products and Services Does RVVQF Offer?
- Cultivates and sells medical cannabis.
- Provides management services to other cannabis companies.
- Offers consulting services in the cannabis industry.
- Engages in specialized research and development activities.
- Markets cannabis products under the Lore Cannabis brand.
- Markets cannabis products under the Bloomera brand.
How Does RVVQF Make Money?
- Generates revenue through the cultivation and sale of medical cannabis products.
- Earns fees by providing management and consulting services to other cannabis businesses.
- Invests in research and development to create new cannabis products and technologies.
What Industry Does RVVQF Operate In?
RavenQuest BioMed Inc. operates within the rapidly evolving cannabis industry, which is experiencing significant growth and regulatory changes. The market is characterized by increasing demand for both medical and recreational cannabis products. RavenQuest competes with other cannabis producers and consulting firms, including AVTBF (Avant Brands Inc.), BBRRF (BevCanna Enterprises Inc.), CANN (Cronos Group Inc.), CPIVF (Canopy Rivers Inc.), and MVMDF (MediPharm Labs Corp.). The industry is subject to evolving regulations and licensing requirements, impacting market entry and operational costs.
Who Are RVVQF's Key Customers?
- Medical cannabis patients.
- Recreational cannabis consumers (where legally permitted).
- Other cannabis companies seeking management and consulting services.
RVVQF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in RavenQuest's growth potential, indicating that leadership believes in the company's future prospects.
- Community sentiment has shifted positively, with increased discussions around the company's innovative approaches in the cannabis sector.
- Recent developments in regulatory approvals for cannabis products have created a more favorable environment for companies like RavenQuest.
- Increased partnerships and collaborations have been reported, enhancing RavenQuest's market presence and expanding its operational capabilities.
Bear Case
- Concerns about the overall volatility in the cannabis market have led to skepticism among investors regarding long-term sustainability.
- Negative sentiment from some community discussions highlights fears of potential regulatory challenges that could impact RavenQuest's operations.
- Recent financial reports indicate ongoing struggles with profitability, raising doubts about the company's ability to scale effectively in a competitive landscape.
- Market perception remains cautious, with some analysts questioning the viability of RavenQuest's business model in the current economic climate.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
RVVQF Latest News
-
Stocks That Hit 52-Week Lows On Friday
· Jan 31, 2020
-
Stocks That Hit 52-Week Lows On Thursday
· Oct 3, 2019
-
Stocks That Hit 52-Week Lows On Wednesday
· Oct 2, 2019
-
Stocks That Hit 52-Week Lows On Tuesday
· Oct 1, 2019
RVVQF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for RVVQF.
Price Targets
Wall Street price target analysis for RVVQF.
RVVQF MoonshotScore
What does this score mean?
The MoonshotScore rates RVVQF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: David Allen Cross
CEO
David Allen Cross serves as the CEO of RavenQuest BioMed Inc. His background includes experience in corporate management and strategic development within emerging industries. Cross has been involved in guiding companies through periods of growth and transformation, with a focus on optimizing operational efficiency and market positioning. His expertise spans various sectors, including resource management and technology, bringing a diverse perspective to the cannabis industry.
Track Record: Under David Allen Cross's leadership, RavenQuest BioMed Inc. has focused on expanding its cannabis cultivation and consulting services. Key milestones include the development of the Lore Cannabis and Bloomera brands and efforts to navigate the evolving regulatory landscape in Canada. Cross has emphasized strategic partnerships and product innovation to drive growth and market share.
RVVQF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that RavenQuest BioMed Inc. may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same regulatory oversight as exchange-listed companies. Investing in OTC Other stocks carries significant risks due to the potential for limited information and higher volatility compared to stocks listed on major exchanges like the NYSE or NASDAQ. This tier often includes companies with distressed financials or those that are newly formed and have yet to establish a strong track record.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure.
- Lower trading volume and liquidity.
- Higher price volatility.
- Potential for fraud or manipulation.
- Lack of regulatory oversight.
- Verify the company's financial statements and disclosures.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Review the company's regulatory filings and compliance history.
- Evaluate the company's liquidity and trading volume.
- Consult with a financial advisor.
- Understand the risks associated with OTC investing.
- Established brands (Lore Cannabis and Bloomera).
- Active in the cannabis industry since 2017.
- Operations in Canada.
- Presence of a CEO (David Allen Cross).
RavenQuest BioMed Inc. Healthcare Stock: Key Questions Answered
What does RavenQuest BioMed Inc. do?
RavenQuest BioMed Inc. is a Canadian cannabis company involved in the production, management, and consulting aspects of the cannabis industry. It operates through two segments: Consulting Business, offering expertise to other cannabis companies, and Cultivation and Sale of Medical Cannabis, producing and distributing cannabis products under the Lore Cannabis and Bloomera brands. The company focuses on expanding its cultivation capabilities, developing innovative cannabis products, and adapting to the evolving regulatory landscape within the cannabis sector.
What do analysts say about RVVQF stock?
As of March 16, 2026, there is limited analyst coverage specifically for RVVQF stock due to its OTC listing and micro-cap status. Key valuation metrics such as P/E ratio (-0.00) and profit margin (-2423.9%) indicate significant financial challenges. Growth considerations include potential regulatory changes in the cannabis industry and expansion of its product lines. Investors should conduct thorough due diligence and consider the risks associated with OTC-listed companies and the volatile nature of the cannabis market.
What are the main risks for RVVQF?
The main risks for RavenQuest BioMed Inc. include intense competition in the cannabis industry, fluctuating cannabis prices, and dependence on evolving cannabis regulations. The company's negative profit margin (-2423.9%) and limited market capitalization ($0.00B) indicate financial vulnerabilities. As an OTC-listed stock, RVVQF faces additional risks such as limited financial disclosure, lower trading volume, and higher price volatility. Potential negative publicity and reputational damage also pose a threat to the company's brand and market position.
What are the key factors to evaluate for RVVQF?
RavenQuest BioMed Inc. (RVVQF) holds an AI score of 61/100 (moderate). Not financial advice.
How frequently does RVVQF data refresh on this page?
RVVQF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven RVVQF's recent stock price performance?
RavenQuest BioMed Inc. (RVVQF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established brands (Lore Cannabis and Bloomera). See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider RVVQF overvalued or undervalued right now?
Valuing RavenQuest BioMed Inc. (RVVQF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying RVVQF?
Before investing in RavenQuest BioMed Inc. (RVVQF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available for OTC-listed companies.
- Financial data may not be up-to-date.